Otsuka Pakistan Limited (PSX:OTSU)
188.81
-1.32 (-0.69%)
At close: Mar 24, 2025
Otsuka Pakistan Revenue
Otsuka Pakistan had revenue of 972.79M PKR in the quarter ending December 31, 2024, with 25.00% growth. This brings the company's revenue in the last twelve months to 3.37B, up 11.95% year-over-year. In the fiscal year ending June 30, 2024, Otsuka Pakistan had annual revenue of 3.16B with 4.24% growth.
Revenue (ttm)
3.37B
Revenue Growth
+11.95%
P/S Ratio
0.65
Revenue / Employee
9.78M
Employees
345
Market Cap
2.19B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 3.16B | 128.78M | 4.24% |
Jun 30, 2023 | 3.04B | 183.35M | 6.43% |
Jun 30, 2022 | 2.85B | 305.46M | 12.00% |
Jun 30, 2021 | 2.55B | 319.29M | 14.34% |
Jun 30, 2020 | 2.23B | 342.24M | 18.16% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GlaxoSmithKline Pakistan | 61.19B |
Abbott Laboratories (Pakistan) | 68.18B |
AGP Limited | 25.03B |
The Searle Company | 28.80B |
Highnoon Laboratories | 24.63B |
Shifa International Hospitals | 25.45B |
Citi Pharma | 13.19B |
Ferozsons Laboratories | 16.82B |